key: cord-0760130-k6cumncp authors: Ludvigsson, Jonas F. title: Case report and systematic review suggest that children may experience similar long‐term effects to adults after clinical COVID‐19 date: 2020-12-03 journal: Acta Paediatr DOI: 10.1111/apa.15673 sha: 74e6e05308ec866d5e779ef3ae3101760f7e6329 doc_id: 760130 cord_uid: k6cumncp AIM: Persistent symptoms in adults after COVID‐19 are emerging and the term long COVID is increasingly appearing in the literature. However, paediatric data are scarce. METHODS: This paper contains a case report of five Swedish children and the long‐term symptoms reported by their parents. It also includes a systematic literature review of the MEDLINE, EMBASE and Web of Science databases and the medRxiv/bioRxiv pre‐print servers up to 2 November 2020. RESULTS: The five children with potential long COVID had a median age of 12 years (range 9–15) and four were girls. They had symptoms for 6–8 months after their clinical diagnoses of COVID‐19. None were hospitalised at diagnosis, but one was later admitted for peri‐myocarditis. All five children had fatigue, dyspnoea, heart palpitations or chest pain, and four had headaches, difficulties concentrating, muscle weakness, dizziness and sore throats. Some had improved after 6–8 months, but they all suffered from fatigue and none had fully returned to school. The systematic review identified 179 publications and 19 of these were deemed relevant and read in detail. None contained any information on long COVID in children. CONCLUSION: Children may experience similar long COVID symptoms to adults and females may be more affected. of individuals with COVID-19 have the persistent symptoms that are characteristic of long COVID. 5 Symptoms in adults include fatigue, headache, dyspnoea, cognitive impairment, depression, skin rashes and gastrointestinal complaints. While there is a growing body of literature on long COVID in adults, [5] [6] [7] the data on children are scarce. The aim of this paper was to describe five children with long COVID, based on parental reports, and complement those cases with a systematic literature review of long COVID. In late October 2020, I was one of a number of physicians and healthcare personnel who were contacted by the parents of three children who had met on an Internet-based social media forum after their children were diagnosed with COVID-19. They had noted our interest in COVID-19 and were keen to raise awareness of the ongoing symptoms that their children were experiencing after contracting the virus. When I expressed interest in their reports, a further two parents contacted me. My contact with them was limited to clarifying their parental reports, obtaining written, informed consent for their children's data to be used in this paper and assuring them that any data that were used would be anonymised. The different areas of data gathered were decided after hearing the histories of the families. Separate consent was obtained from children aged 12 years or more. In this Swedish case report, we defined long COVID as persistent symptoms that lasted for 2 months or more, as this corresponded to the mean duration reported by Carfi et al.'s 7 follow-up of 143 adults, which found that 87% had persistent symptoms after COVID-19. All the data are based on parental reports of the five children. November 2020 to identify papers on long COVID in children. In addition, the librarian also performed a search of medical papers filed on medRxiv/bioRxiv up to the same date. This is a pre-print database for biology papers, which is operated by the Cold Spring Harbor Laboratory, a private research and educational institution in New York, USA. We used the same search terms for COVID-19 and SARS-CoV-2 and children as we did in our two previous systematic reviews of 9 However, we also added following terms, and variants of these terms, to specifically catch publications that discussed long COVID: chronic, post-acute, post-COVID, long COVID, long haulers, persistent, sequelae or complications. Details of the searches can be found in Appendix S1. After the duplicates were removed, the search identified 179 papers: 82 in MEDLINE, 20 in EMBASE, 58 in Web of Science and 19 in medRxiv/bioRxiv. The author read 19 in detail after screening the titles and abstracts. Of these, 11 were from MEDLINE, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] two from EMBASE, 21, 22 five from Web of Science 23-27 and one from medRxiv/bioRxiv. 28 There was no pre-specified protocol prior to the review. Of the five children with potential long COVID, four were girls and their median age was 12 years (range 9-15). The children had experienced symptoms for between 6 and 8 months. All had been diagnosed with COVID-19 by their physician. None of the children had positive SARS-CoV-2 polymerase chain reactions, but the tests had been obtained more than 1.5 months after the onset of COVID-19. SARS-CoV-2 antibody testing had been carried out on four of the five children, but all the tests were negative. It was not necessary for any of the children to be admitted to hospital at the onset of COVID-19. The clinical details of the children, based on parental reports, are presented in Table 1 . Only one child had comorbidities before developing COVID-19 and that was a 12-year-old female with asthma, allergies and mild autism spectrum disorder. The most common symptoms 2 months after the onset of COVID-19 were fatigue, dyspnoea and heart palpitations or chest pain. These were seen in all five of the children. In addition, four of the five children complained of headaches, difficulties concentrating, muscle weakness, dizziness and a sore throat. The parents reported that three of the children experienced abdominal pain, memory loss, depression and skin rashes and muscle pain. Less common symptoms, experienced by two children, were remitting fever, sleep disorders, joint pain, diarrhoea and vomiting and hyperanaesthesia A number of symptoms were each reported • This paper presents a case report of five Swedish children aged 9-15 and the parental reported symptoms they experienced more than 2 months after clinical diagnoses of COVID-19. • All had fatigue, dyspnoea, heart palpitations or chest pain, four had headaches, difficulties concentrating, muscle weakness, dizziness and sore throats and females appeared to be over represented. • The accompanying systematic review did not reveal any data on long COVID in children. TA B L E 1 Background details and clinical data reported by the parents of five children with long-term effects of COVID-19 TA B L E 1 (Continued) by one child after 2 months, and they were persistent deranged smell and taste, poor appetite, a chronic cough and numbness. Some of the children had improved after experiencing symptoms for 6-8 months, but all of them still suffered from fatigue and none of them had been able to return to school full time. Four reported daily problems of some kind while a fifth was reported to have 'good and bad days'. The parents stated that two of the children had undergone cardiac examinations and two had seen, or were scheduled to see, a psychologist. The girl with prior comorbidities was hospitalised for 3 days for peri-myocarditis after being diagnosed with COVID-19. Several parents also reported that they or the children's siblings also had longstanding issues as a result of COVID-19. These included the mothers and two siblings of patient four (Table 1 ). One parent noted that it was general knowledge on Internetbased social forums for long COVID patients that mothers and their daughters often had long COVID simultaneously. In a systematic review, Ahmed et al. 10 I was unable to access a case report of four adolescents with skin lesions, 2 weeks after the occurrence of a flu-like syndrome. 18 The patients tested positive for SARS-CoV-2 antibodies, but it was not clear from the abstract if these potential cutaneous manifestations persisted for more than 2 months. This paper presents detailed parent reported data on five children with potential long COVID that lasted for more than 2 months, which was the mean duration reported by Carfi Of the five children in our case report, four were female and that ratio of 4:1 was also reported by a French study. The hospital saw some 30 patients weeks with persistent symptoms and noted that many were females around 40 years of age. 30 Since the data were adults. 30 None of the children was admitted to hospital at the onset of COVID-19, but the girl with prior comorbidities did spend 3 days in hospital with peri-myocarditis 3 months after she was diagnosed with COVID-19. In addition, many adults with long COVID have had mild initial disease. Carfi et al. 7 described the 143 adults admitted to hospital for COVID-19, who were followed up at an average of 60 days after disease onset, in a research letter to JAMA. Of these more than 87% had at least one persistent symptom and most frequent were fatigue, dyspnoea, joint pain and chest pain. All five children in our study reported fatigue and dyspnoea, but joint pain and chest pain were also common. Other symptoms ranged from neurological complaints to skin rashes, sleep disorders, depression, muscle pain and remitting fever. However, fatigue seems to stand out as the predominant symptom and it persisted at end of follow-up in all five children. In a paper by Rubin, 6 unpublished data from 1500 long COVID adult patients showed fatigue to be the most frequent persisting symptom. Long-term fatigue is not uncommon after other viral infections. 31 When Lam et al. 32 followed up 369 severe acute respiratory syndrome survivors 4 years after they developed the disease in the first decade of this century, they found that more than 40% reported fatigue. Although it is often overlooked, 10, 15, 25 and that chest pain is common in adults. 5, 7 It is notable that several of the children in our case report had palpitations, with a high pulse rate on exertion and an inability to perform physical activity. In addition, the only child who was hospitalised in our case report had peri-myocarditis. The children in our case report also experienced gastrointestinal, neurological and cognitive symptoms, which were all consistent with the extra-pulmonary manifestations reported in acute COVID-19 patients. 5, 35 It is interesting that sometimes several people in the same family as the children in this report had long COVID. This suggests that shared genetic or environmental traits might predispose some individuals to long COVID. Most children with COVID-19 show few symptoms and have a mild form of the disease. 8 However, it has become clear that a small proportion develop MIS-C 10 and some may even need intensive care. 13 Although the current systematic review found no earlier reports of long COVID, the five children aged 9-15 years in our case report testify to the existence of long-term complications from COVID-19 in children. While I was writing this case report, I became aware of even more children with long COVID, as more parents contacted me, but these were not included in this case report. This study had some strengths and limitations. One strength was the systematic search of a number of highly respected medical databases, including the medRxiv/bioRxiv pre-print servers. Despite our extensive search, I failed to identify any report that specifically described long COVID in children. The limitations of our review include the lack of granular data on blood tests and other investigations to rule out differential diagno- It is possible that the children in this case report have more severe long COVID than the average child. The fact that their parents reached out to the medical community may also signal that their children had a severe form of long COVID. Although all of the five children had been diagnosed with COVID-19 by their respective physicians, none of them had been tested positive for COVID-19 at the time of their diagnosis. It worth noting that it has been suggested that a positive test is not required for a diagnosis of long COVID. 5 That fact that the polymerase chain reaction tests for SARS-CoV-2 were negative is not surprising, since they were not obtained during the acute phase of COVID-19. Sweden suffered from a lack of testing equipment during spring 2020 when these children fell sick, 29 and testing was primarily targeted at hospital inpatients and healthcare personnel. Still I acknowledge that other explanations for the ongoing symptoms cannot be fully ruled out. None of the children were admitted to hospital during spring 2020, but patient two was later admitted for peri-myocarditis. This case report on five children and the accompanying systematic review add to the growing evidence that long COVID may potentially occur also in children and that it can be very debilitating and lead to long school absences. The symptoms that were reported by the children's parents were similar to those reported by studies of adults with long COVID. The case report and the growing number of parents that have made contact suggest that females may be more prone to developing long COVID, as seen in adult studies. I am grateful to librarian Love Strandberg at the Karolinska Institutet University Library in Stockholm, Sweden, who performed the literature search. None. Jonas F. Ludvigsson https://orcid.org/0000-0003-1024-5602 A novel coronavirus from patients with pneumonia in China Clinical characteristics of coronavirus disease 2019 in China Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Hyperinflammatory shock in children during COVID-19 pandemic Management of postacute COVID-19 in primary care As their numbers grow, COVID-19 "Long Haulers" Stump experts Persistent symptoms in patients after acute COVID-19 Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Children are unlikely to be the main drivers of the COVID-19 pandemic -a systematic review Multisystem inflammatory syndrome in children: a systematic review The rise of adverse childhood experiences during the COVID-19 pandemic Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study Sequelae of COVID-19 in hospitalized children: a 4-months follow-up Cardiac involvement in children with COVID-19 Short-and potential long-term adverse health outcomes of COVID-19: a rapid review Cerebral micro-structural changes in COVID-19 patients -an MRI-based 3-month follow-up study Erythema pernio-like in four adolescents in the era of the coronavirus-2 infection Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network -United States Inpatient neurology consultations during the onset of the SARS-CoV-2 New York city pandemic: a single center case series Chest X-ray findings monitoring COVID-19 disease course and severity Unleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease The epidemiology of COVID-19: a review Assessment of cardiac arrhythmic risk in children with Covid-19 infection Autoimmune and inflammatory diseases following COVID-19 Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study Three-month outcomes in hospitalized COVID-19 patients The first eight months of Sweden's COVID-19 strategy and the key actions and actors that were involved Post-COVID-19 chronic symptoms: a postinfectious entity? Active Epstein-Barr virus infection in post-viral fatigue syndrome Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population-and registry-based cohort study with over 2 years of follow-up Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19) Extrapulmonary manifestations of COVID-19 Child health systems in Sweden